ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.09% | -39.26% | 96.00% | -62.39% | -88.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.09% | -39.26% | 96.00% | -62.39% | -88.62% |
| Cost of Revenue | -69.08% | -62.54% | 78.45% | -45.16% | -75.49% |
| Gross Profit | 573.55% | 976.67% | 106.15% | -107.09% | -102.40% |
| SG&A Expenses | -33.30% | -43.94% | 129.86% | -7.22% | -30.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.12% | -48.99% | 208.36% | -25.33% | -51.15% |
| Operating Income | 46.13% | 52.00% | -44.47% | -22.52% | -55.17% |
| Income Before Tax | 52.35% | 42.18% | -54.44% | -34.05% | -57.71% |
| Income Tax Expenses | 134.06% | -- | 599.52% | -52.55% | -55.16% |
| Earnings from Continuing Operations | 18.14% | 15.31% | -282.69% | -28.13% | -58.81% |
| Earnings from Discontinued Operations | -- | 1,266.53% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.32% | 163.30% | -292.63% | -28.13% | -78.87% |
| EBIT | 46.13% | 52.00% | -44.47% | -22.52% | -55.17% |
| EBITDA | 55.29% | 63.81% | -62.43% | -18.48% | -71.91% |
| EPS Basic | 66.94% | 132.43% | -217.47% | -15.34% | -59.55% |
| Normalized Basic EPS | 84.83% | 73.13% | -11.14% | -20.66% | -40.65% |
| EPS Diluted | 66.31% | 132.43% | -217.47% | -16.67% | -59.89% |
| Normalized Diluted EPS | 84.83% | 73.13% | -11.14% | -20.66% | -40.65% |
| Average Basic Shares Outstanding | 119.93% | 95.25% | 18.92% | 11.09% | 12.13% |
| Average Diluted Shares Outstanding | 119.93% | 95.25% | 18.92% | 11.09% | 12.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |